OPN1SW and acute lymphoblastic leukemia: To study the process of CREs modulation during BCP-ALL progression, we surveyed the variability of each 150,123 identified CRE by performing differential analysis among patients in the healthy, onset, remission, and relapse groups (Fig. 1C-D).